Alexion

European Union flags waving in front of the EU Parliament building in Brussels
Pharma

Europe recommends Novo's Frehemgo and AZ's Klygefa

AstraZeneca snagged a recommendation from the CHMP, setting dual-binding nanobody C5 inhibitor Klygefa up for a formal approval in Europe.
Donavyn Coffey Sep 18, 2026 11:23am
Ultomiris

AZ's Ultomiris hits goal in ph. 3 IgAN trial

Apr 21, 2026 10:35am
FDA

AZ to pull bleeding reversal agent after FDA flags risk imbalance

Dec 19, 2025 1:12pm
chess pieces game competition

Novartis sues AZ's Alexion over 'misleading' Ultomiris marketing

Oct 22, 2025 1:19pm
Alexion Rare Connections in gMG short film

AZ's Alexion spotlights gMG for next awareness-raising film

Jul 31, 2025 12:42pm
AZ

AZ touts Ultomiris results in post-transplant complication trial

Jun 16, 2025 10:32am